Evidence map›Paper›PMID 40733720›Full record

ArticleVaccines2025

Immunogenicity, Efficacy and Twelve-Month Storage Stability Studies of a Lyophilized Rabies mRNA Vaccine.

Chen Chen, Dandan Ling, Kai Ji, Liang Tang, Xiaojing Zhang, Xishan Lu, Xuemei Leng, Changyao Tan, Hongchao Wu, Wenqiang Pang and 6 more

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chen ChenSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.
Dandan LingSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.
Kai JiSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.
Liang TangSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.
Xiaojing ZhangSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.
Xishan LuSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.
Xuemei LengJiangsu CuroVax Co., Ltd., Changzhou 213032, China.
Changyao TanJiangsu CuroVax Co., Ltd., Changzhou 213032, China.
Hongchao WuNational Research Center for Veterinary Medicine, Luoyang 560119, China.
Wenqiang PangNational Research Center for Veterinary Medicine, Luoyang 560119, China.
Quanren HeSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.
Jerry ZhangSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.
Peng GaoSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.
Xiaotao WangSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.
Linhui WangSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.ORCID 0009-0000-0659-002X
Bo YingSuzhou Abogen Biosciences Co., Ltd., Suzhou 215123, China.ORCID 0009-0000-3453-1836

Funding

National Center of Technology Innovation for Biopharmaceuticals NCTIB2022HS03003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

beagleslipid nanoparticleslong-term stabilitylyophilizationmRNA vaccinerabies

Identifiers

PMID40733720
PMCPMC12299307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.